These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34544381)

  • 1. Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy.
    Jahnen M; Mynzak E; Meissner VH; Schiele S; Schulwitz H; Ankerst DP; Gschwend JE; Herkommer K; Dinkel A
    BMC Cancer; 2021 Sep; 21(1):1041. PubMed ID: 34544381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-related self-perception in men affected by prostate cancer after radical prostatectomy.
    Jahnen M; Lehner L; Meissner VH; Andreas Dinkel ; Schiele S; Schulwitz H; Gschwend JE; Herkommer K
    J Cancer Surviv; 2024 Apr; 18(2):509-520. PubMed ID: 36098942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit finding in men affected by prostate cancer prior to and following radical prostatectomy - a cross-sectional study with a stratified sample.
    Jahnen M; Bayer P; Meissner VH; Schiele S; Schulwitz H; Gschwend JE; Herkommer K; Dinkel A
    BMC Cancer; 2023 Jun; 23(1):508. PubMed ID: 37277755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fear of cancer recurrence and disease progression in long-term prostate cancer survivors after radical prostatectomy: A longitudinal study.
    Meissner VH; Olze L; Schiele S; Ankerst DP; Jahnen M; Gschwend JE; Herkommer K; Dinkel A
    Cancer; 2021 Nov; 127(22):4287-4295. PubMed ID: 34358337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit finding in long-term prostate cancer survivors.
    Lassmann I; Dinkel A; Marten-Mittag B; Jahnen M; Schulwitz H; Gschwend JE; Herkommer K
    Support Care Cancer; 2021 Aug; 29(8):4451-4460. PubMed ID: 33447865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lived experience of prostate cancer: 10-year survivor perspectives following contemporary treatment of localized prostate cancer.
    Al Hussein Al Awamlh B; Wallis CJD; Diehl C; Barocas DA; Beskow LM
    J Cancer Surviv; 2024 Aug; 18(4):1370-1383. PubMed ID: 37171717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-related identity and positive affect in survivors of prostate cancer.
    Bellizzi KM; Blank TO
    J Cancer Surviv; 2007 Mar; 1(1):44-8. PubMed ID: 18648944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
    Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy.
    Lunger L; Meissner VH; Kopp BCG; Dinkel A; Schiele S; Ankerst DP; Gschwend JE; Herkommer K
    BMC Urol; 2023 Aug; 23(1):139. PubMed ID: 37612591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.
    Meissner VH; Herkommer K; Marten-Mittag B; Gschwend JE; Dinkel A
    J Cancer Surviv; 2017 Dec; 11(6):800-807. PubMed ID: 28528448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fear of cancer recurrence in prostate cancer survivors.
    van de Wal M; van Oort I; Schouten J; Thewes B; Gielissen M; Prins J
    Acta Oncol; 2016 Jul; 55(7):821-7. PubMed ID: 26935517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
    Loeb S; Feng Z; Ross A; Trock BJ; Humphreys EB; Walsh PC
    J Urol; 2011 Aug; 186(2):500-5. PubMed ID: 21679999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Specific Antigen Testing after Radical Prostatectomy-Can We Stop at 20 Years?
    Ludwig WW; Feng Z; Trock BJ; Humphreys E; Walsh PC
    J Urol; 2018 Jan; 199(1):114-119. PubMed ID: 28818527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social constraints and psychological well-being after prostate cancer: A follow-up at 12 and 24 months after surgery.
    Stinesen Kollberg K; Thorsteinsdottir T; Wilderäng U; Hugosson J; Wiklund P; Bjartell A; Carlsson S; Stranne J; Haglind E; Steineck G
    Psychooncology; 2018 Feb; 27(2):668-675. PubMed ID: 29024232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial and Functional Predictors of Mental Disorder among Prostate Cancer Survivors: Informing Survivorship Care Programs with Evidence-Based Knowledge.
    Massoeurs L; Ilie G; Lawen T; MacDonald C; Bradley C; Vo JDC; Rutledge RDH
    Curr Oncol; 2021 Oct; 28(5):3918-3931. PubMed ID: 34677252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
    Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.
    Shrader-Bogen CL; Kjellberg JL; McPherson CP; Murray CL
    Cancer; 1997 May; 79(10):1977-86. PubMed ID: 9149026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.